financetom
Business
financetom
/
Business
/
'Asia's MicroStrategy' Metaplanet Down 70% Since June, Company Value Falls Below $3.4B Bitcoin Reserves
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
'Asia's MicroStrategy' Metaplanet Down 70% Since June, Company Value Falls Below $3.4B Bitcoin Reserves
Oct 14, 2025 6:26 AM

Metaplanet Inc. ( MTPLF ) shares fell to $3.45 on Tuesday, extending a months-long slide that has erased 70% of the company's value and pushed its market capitalization below the worth of its Bitcoin reserves.

Market Discounts Metaplanet's Bitcoin Holdings

The Tokyo-based company, once hailed as Japan's equivalent to Strategy Inc. ( MSTR ) , is now confronting a sharp reversal in its fortunes.

After pivoting from hospitality to Bitcoin (CRYPTO: BTC) investment in April 2024, Metaplanet's ( MTPLF ) stock initially soared as traders embraced its crypto-treasury strategy.

That optimism has since evaporated. The company's market value and debt combined now total less than the value of its Bitcoin holdings, with its market-to-net-asset-value ratio (mNAV) briefly falling to 0.99 on Tuesday. 

This indicates that investors are valuing the firm below its own Bitcoin reserves which is a rare scenario for listed crypto-treasury firms.

Technical Breakdown Deepens Losses

Metaplanet Inc. ( MTPLF ) Price Dynamics (Source: TradingView)

On the charts, Metaplanet Inc. ( MTPLF ) continues to extend its decline within a well-defined descending channel, with price now testing the lower boundary near $3.40.

The stock remains capped under the 20-day EMA at $4.01, reinforcing the dominance of sellers.

Momentum indicators confirm the weakness, with RSI hovering near 34, reflecting persistent bearish pressure but nearing oversold territory.

A sustained break below $3.30 could expose the next downside zone near $2.80, while recovery attempts will face immediate resistance at $4.00 and stronger hurdles at $5.00.

The broader trend remains negative unless price reclaims the mid-channel and key moving averages.

Analysts See Bubble Deflation in Crypto Treasury Stocks

Mark Chadwick, a Japan equity analyst writing on Smartkarma, said Metaplanet's ( MTPLF ) collapse reflects "a popping of a bubble" in crypto-treasury stocks — companies that gained attention for holding digital assets on their balance sheets as proxies for direct Bitcoin exposure.

"While the euphoria has cooled, some Bitcoin believers might see this as a good moment to buy the stock cheap," Chadwick said.

Company Continues Expanding Bitcoin Holdings

Despite the selloff, Metaplanet ( MTPLF ) continues to accumulate Bitcoin.

Company filings show holdings of more than 30,000 BTC, valued around $3.4 billion.

In September, shareholders approved an international equity sale that raised about $1.4 billion to fund additional Bitcoin purchases.

Why It Matters

Metaplanet's ( MTPLF ) collapse is more than just a single stock story. 

It shows how markets are starting to discount even hard Bitcoin holdings when confidence in the corporate wrapper breaks down. 

Japan's "Bitcoin treasury" was once seen as a clean equity proxy for BTC exposure, but the crash below its reserve value flips that logic on its head. 

For institutional investors, the message is clear: Bitcoin itself may be trusted, but listed companies using it as a balance-sheet strategy are no longer guaranteed a premium. 

This disconnect could redefine how Wall Street and Tokyo price future corporate crypto treasuries compared with direct Bitcoin holdings.

Read Next:

BlackRock Hits $13.5 Trillion AUM, CEO Sees Building Momentum

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sentinelone Insider Sold Shares Worth $1,140,682, According to a Recent SEC Filing
Sentinelone Insider Sold Shares Worth $1,140,682, According to a Recent SEC Filing
Sep 11, 2024
05:00 PM EDT, 09/10/2024 (MT Newswires) -- Ric Smith, Chief Product & Technology Officer, on September 06, 2024, sold 51,052 shares in Sentinelone ( S ) for $1,140,682. Following the Form 4 filing with the SEC, Smith has control over a total of 585,647 shares of the company, with 585,647 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1583708/000158370824000078/xslF345X05/wk-form4_1726001520.xml ...
Abercrombie & Fitch Insider Sold Shares Worth $2,501,264, According to a Recent SEC Filing
Abercrombie & Fitch Insider Sold Shares Worth $2,501,264, According to a Recent SEC Filing
Sep 11, 2024
05:10 PM EDT, 09/10/2024 (MT Newswires) -- Samir Desai, Executive Vice President, Chief Digital & Technology Officer, on September 06, 2024, sold 19,041 shares in Abercrombie & Fitch ( ANF ) for $2,501,264. Following the Form 4 filing with the SEC, Desai has control over a total of 27,985 shares of the company, with 27,985 shares held directly. SEC Filing:...
Westaim Completes US$79-Million Sale of Remaining Interest in Skyward Specialty Insurance
Westaim Completes US$79-Million Sale of Remaining Interest in Skyward Specialty Insurance
Sep 11, 2024
05:02 PM EDT, 09/10/2024 (MT Newswires) -- Westaim ( WEDXF ) after trade Tuesday said it sold all its remaining 1.91-million shares in Skyward Specialty Insurance Group. The investment-holding company said proceeds, less commissions, were approximately US$79 million. Westaim's ( WEDXF ) remaining investments include significant interests in Arena and the Arena FINCOs. The company's shares closed down $0.04 to...
BridgeBio to stop development of therapy for genetic disorder
BridgeBio to stop development of therapy for genetic disorder
Sep 11, 2024
Sept 10 (Reuters) - BridgeBio Pharma ( BBIO ) said on Tuesday it will stop development of its experimental therapy for a genetic disease that affects the adrenaline-producing gland. The drugmaker said the results of its early-to-mid stage study testing the therapy did not meet the threshold to warrant additional capital investment. (Reporting by Puyaan Singh; Editing by Shinjini Ganguli)...
Copyright 2023-2026 - www.financetom.com All Rights Reserved